Bimekizumab Treatment for Scalp Psoriasis: A 52-Week, Real-World, Retrospective Study. Stefanaki I, Koumprentziotis IA, Rompoti N, Panagakis P, et al. Int J Dermatol 2025 Jan 16. doi: 10.1111/ijd.17658.

Read + Share

Amedeo Smart

Independent Medical Education

Stefanaki I, Koumprentziotis IA, Rompoti N, Panagakis P, et al. Bimekizumab Treatment for Scalp Psoriasis: A 52-Week, Real-World, Retrospective Study. Int J Dermatol 2025 Jan 16. doi: 10.1111/ijd.17658.
PMID: 39821776